Moreover, because of the difficulty in estimating tumour burden, based on the absence of changes in overall liver weights or liver tumour area via histological analysis, we can only speculate that administration of ACVR2B/Fc did not exert anti‐tumour effects. The gene discussed is ACVR2B; the disease is neoplasm.